Helping Women Understand Treatment Options for Vulvar and Vaginal Atrophy.
Vulvar and vaginal atrophy (VVA) is a common and progressive medical condition in postmenopausal women. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey assessed knowledge about VVA and its impact in 3,046 postmenopausal U.S. women, and recorded women's attitudes about their interactions with health care providers and about available treatments. REVIVE identified poor disease awareness and understanding among women, failure of health care professionals to evaluate women for VVA signs and symptoms, low treatment rates and concerns about the safety and efficacy of available therapies. Strategies to address these needs include proactive screening, education for women and clinicians about VVA and recommendations for treatment and follow-up.
Diane M
DM
Parks
Jeffrey
J
Levine
D000368:Aged; D001284:Atrophy / Q000451:nursing / Q000473:pathology*; D005260:Female; D006801:Humans; D008427:Maternal Health Services; D008875:Middle Aged; D020380:Needs Assessment; D011795:Surveys and Questionnaires; D014621:Vagina / Q000503:physiopathology*; D014844:Vulva / Q000503:physiopathology*
REVIVE survey; dyspareunia; postmenopausal women; vaginal dryness; vulvar and vaginal atrophy